Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Boersma

Showing results (221-230 of 679) with videos related to

Pageof 68
Sort By:
Archives of Internal Medicine|July 11, 2007
Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trialJorik R Timmer, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
Archives of Physical Medicine and Rehabilitation|January 7, 2020
Association Between Exercise Capacity and Health-Related Quality of Life During and After Cardiac Rehabilitation in Acute Coronary Syndrome Patients: A Substudy of the OPTICARE Randomized Controlled TrialMarie de Bakker, Iris den Uijl, Nienke Ter Hoeve, et al.
Atherosclerosis|August 31, 2020
The age- and sex-specific composition of atherosclerotic plaques in vascular surgery patientsMarie de Bakker, Nathalie Timmerman, Ian D van Koeverden, et al.
Journal of the American College of Cardiology|September 5, 2006
Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkersCynthia M Westerhout, Yuling Fu, Michael S Lauer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patientsClaudia Ypenburg, Martin J Schalij, Gabe B Bleeker, et al.
Heart (British Cardiac Society)|September 8, 2019
Growth differentiation factor-15 as candidate predictor for mortality in adults with pulmonary hypertensionLaurie W Geenen, Vivan J M Baggen, Robert M Kauling, et al.
European Heart Journal|May 14, 2011
Evaluating the 'all-comers' design: a comparison of participants in two 'all-comers' PCI trials with non-participantsSanneke P M de Boer, Mattie J Lenzen, Rohit M Oemrawsingh, et al.
American Heart Journal|December 24, 2018
The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approachLaurie W Geenen, Vivan J M Baggen, Thomas Koudstaal, et al.
American Heart Journal|July 24, 2007
No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trialCynthia M Westerhout, Judy Gnarpe, Wei-Ching Chang, et al.
Heart (British Cardiac Society)|September 29, 2017
Randomised controlled trial of two advanced and extended cardiac rehabilitation programmesMadoka Sunamura, Nienke Ter Hoeve, Rita J G van den Berg-Emons, et al.
Pageof 68

Showing results (221-230 of 679) with videos related to

Sort By:
Pageof 68
Archives of Internal Medicine|July 11, 2007
Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trialJorik R Timmer, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
Archives of Physical Medicine and Rehabilitation|January 7, 2020
Association Between Exercise Capacity and Health-Related Quality of Life During and After Cardiac Rehabilitation in Acute Coronary Syndrome Patients: A Substudy of the OPTICARE Randomized Controlled TrialMarie de Bakker, Iris den Uijl, Nienke Ter Hoeve, et al.
Atherosclerosis|August 31, 2020
The age- and sex-specific composition of atherosclerotic plaques in vascular surgery patientsMarie de Bakker, Nathalie Timmerman, Ian D van Koeverden, et al.
Journal of the American College of Cardiology|September 5, 2006
Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkersCynthia M Westerhout, Yuling Fu, Michael S Lauer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patientsClaudia Ypenburg, Martin J Schalij, Gabe B Bleeker, et al.
Heart (British Cardiac Society)|September 8, 2019
Growth differentiation factor-15 as candidate predictor for mortality in adults with pulmonary hypertensionLaurie W Geenen, Vivan J M Baggen, Robert M Kauling, et al.
European Heart Journal|May 14, 2011
Evaluating the 'all-comers' design: a comparison of participants in two 'all-comers' PCI trials with non-participantsSanneke P M de Boer, Mattie J Lenzen, Rohit M Oemrawsingh, et al.
American Heart Journal|December 24, 2018
The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approachLaurie W Geenen, Vivan J M Baggen, Thomas Koudstaal, et al.
American Heart Journal|July 24, 2007
No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trialCynthia M Westerhout, Judy Gnarpe, Wei-Ching Chang, et al.
Heart (British Cardiac Society)|September 29, 2017
Randomised controlled trial of two advanced and extended cardiac rehabilitation programmesMadoka Sunamura, Nienke Ter Hoeve, Rita J G van den Berg-Emons, et al.
Pageof 68